Labquality EQAS
Respiratory infections multiplex, nucleic acid detection
CLINICAL MICROBIOLOGY
Scheme information
Scheme
Respiratory infections multiplex, nucleic acid detection
Service by
Labquality
Target
Laboratories
Group
Clinical microbiology
Sub-group
Multiplex methods
Products
5300 /
Respiratory infections multiplex, nucleic acid detection
Samples: 4 simulated samples, 1 mL each
Examinations: Direct multiplex nucleic acid detection. Pathogens included are adenovirus, bocavirus, B. parapertussis, B. pertussis, C. pneumoniae, coronavirus (OC43, 229E, NL63, HKU1), enterovirus, influenzavirus A/B, L. pneumophila, metapneumovirus, M. pneumoniae, parainfluenzavirus 1-4, rhinovirus, RSV A/B, SARS-CoV-2 and S. pneumoniae.
Rounds:
FEB, MAY, SEP, NOV
Accrediation: SFS-EN ISO/IEC 17043:2023, FINAS, PT02. The qualitative analysis phase is accredited.
Results/sample set: 1
Additional information: During the period of one calendar year, a comprehensive selection of listed pathogens will be covered. Participation in all rounds throughout the year is strongly recommended to achieve the best possible coverage. The samples include hDNA.